In relation to the cost involved in changing form non-heat-treated to heat-treated material in the northern region, there was an argument as to whether people who were HIV antibody positive should continue to receive contaminated material. Read more about In relation to the cost involved in changing form non-heat-treated to heat-treated material in the northern region, there was an argument as to whether people who were HIV antibody positive should continue to receive contaminated material.
Dr Rotblat delayed reporting Dr David Whitmore's HTLV-3 positive patient because Dr Whitmore had asked for confidentiality regarding the patient while he investigated the patient's lifestyle. Read more about Dr Rotblat delayed reporting Dr David Whitmore's HTLV-3 positive patient because Dr Whitmore had asked for confidentiality regarding the patient while he investigated the patient's lifestyle.
Dr Peter Jones wrote to the Committee on Safety of Medicines setting out his argument for Armour materials to be withheld. Read more about Dr Peter Jones wrote to the Committee on Safety of Medicines setting out his argument for Armour materials to be withheld.
Armour Pharmaceutical Company Limited in the UK was incorporated in 1959. It had several changes in name and parent company and was dissolved in 2010. Read more about Armour Pharmaceutical Company Limited in the UK was incorporated in 1959. It had several changes in name and parent company and was dissolved in 2010.
The Northern Regional Health Authority's position on funding additional cost was yet to be declared. Read more about The Northern Regional Health Authority's position on funding additional cost was yet to be declared.
Contrary to the findings of the Krever Inquiry, Justice Benotto, in a subsequent Canadian criminal case in 2007, found that it would have been unreasonable and irresponsible for Armour to have thrust Prince's studies into the community in a time of great uncertainty. Read more about Contrary to the findings of the Krever Inquiry, Justice Benotto, in a subsequent Canadian criminal case in 2007, found that it would have been unreasonable and irresponsible for Armour to have thrust Prince's studies into the community in a time of great uncertainty.
The Krever Inquiry found that Armour should have informed the Canadian Bureau of Biologics about Dr Prince's findings, but chose not to. Read more about The Krever Inquiry found that Armour should have informed the Canadian Bureau of Biologics about Dr Prince's findings, but chose not to.
Dr Brian Colvin thought that it would be more problematic if the heat-treated commercial products turned out to be unsafe from HIV. Read more about Dr Brian Colvin thought that it would be more problematic if the heat-treated commercial products turned out to be unsafe from HIV.
The CBLA agreed to finance the trial of 8CRV. Read more about The CBLA agreed to finance the trial of 8CRV.
Dr Jones apologised to the DHSS for making public his statement about heat-treated Factor 8 being unsafe. Read more about Dr Jones apologised to the DHSS for making public his statement about heat-treated Factor 8 being unsafe.